Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.

Fletcher RA.; Herrington WG.; Agarwal R.; Mayne KJ.; Arnott C.; Jardine MJ.; Mahaffey KW.; Perkovic V.; Staplin N.; Wheeler DC.; Chertow GM.; Heerspink HJL.; Neuen BL.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.

Fletcher RA., Herrington WG., Agarwal R., Mayne KJ., Arnott C., Jardine MJ., Mahaffey KW., Perkovic V., Staplin N., Wheeler DC., Chertow GM., Heerspink HJL., Neuen BL.

This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2024_09_23_CJASNSeptember19992.mp3.

Original publication

DOI

10.2215/CJN.0000000000000470

Type

Journal

Clin J Am Soc Nephrol

Publication Date

01/09/2024

Volume

Pages

1180 - 1182

Keywords

CKD, cardiovascular, Humans, Sodium-Glucose Transporter 2 Inhibitors, Renal Insufficiency, Chronic, Disease Progression, Cardiovascular Diseases, Cause of Death